IBDEI0B8 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14947,0)
 ;;=V10.83^^95^852^74
 ;;^UTILITY(U,$J,358.3,14947,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14947,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,14947,1,5,0)
 ;;=5^Personal h/o Skin Cancer
 ;;^UTILITY(U,$J,358.3,14947,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,14948,0)
 ;;=V15.1^^95^852^51
 ;;^UTILITY(U,$J,358.3,14948,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14948,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,14948,1,5,0)
 ;;=5^Personal h/o Heart Surgery
 ;;^UTILITY(U,$J,358.3,14948,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,14949,0)
 ;;=V15.82^^95^852^79
 ;;^UTILITY(U,$J,358.3,14949,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14949,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,14949,1,5,0)
 ;;=5^Personal h/o Tobacco Use
 ;;^UTILITY(U,$J,358.3,14949,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,14950,0)
 ;;=V12.01^^95^852^77
 ;;^UTILITY(U,$J,358.3,14950,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14950,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,14950,1,5,0)
 ;;=5^Personal h/o TB
 ;;^UTILITY(U,$J,358.3,14950,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,14951,0)
 ;;=V12.51^^95^852^81
 ;;^UTILITY(U,$J,358.3,14951,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14951,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,14951,1,5,0)
 ;;=5^Personal h/o Venous Thrombosis/Embolism
 ;;^UTILITY(U,$J,358.3,14951,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,14952,0)
 ;;=V17.89^^95^852^25
 ;;^UTILITY(U,$J,358.3,14952,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14952,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,14952,1,5,0)
 ;;=5^Family h/o Musculosk Dis
 ;;^UTILITY(U,$J,358.3,14952,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,14953,0)
 ;;=V12.54^^95^852^76
 ;;^UTILITY(U,$J,358.3,14953,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14953,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,14953,1,5,0)
 ;;=5^Personal h/o Stroke w/o Residual
 ;;^UTILITY(U,$J,358.3,14953,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,14954,0)
 ;;=V15.88^^95^852^50
 ;;^UTILITY(U,$J,358.3,14954,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14954,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,14954,1,5,0)
 ;;=5^Personal h/o Fall(s)
 ;;^UTILITY(U,$J,358.3,14954,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,14955,0)
 ;;=V15.52^^95^852^80
 ;;^UTILITY(U,$J,358.3,14955,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14955,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,14955,1,5,0)
 ;;=5^Personal h/o Traum Brain Inj
 ;;^UTILITY(U,$J,358.3,14955,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,14956,0)
 ;;=V12.55^^95^852^70
 ;;^UTILITY(U,$J,358.3,14956,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14956,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,14956,1,5,0)
 ;;=5^Personal h/o Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,14956,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,14957,0)
 ;;=V58.61^^95^852^1
 ;;^UTILITY(U,$J,358.3,14957,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14957,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,14957,1,5,0)
 ;;=5^Anticoag Rx,Chronic
 ;;^UTILITY(U,$J,358.3,14957,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,14958,0)
 ;;=V12.72^^95^852^2
 ;;^UTILITY(U,$J,358.3,14958,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14958,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,14958,1,5,0)
 ;;=5^Colon Polyps (Removed)
 ;;^UTILITY(U,$J,358.3,14958,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,14959,0)
 ;;=V25.09^^95^852^3
 ;;^UTILITY(U,$J,358.3,14959,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14959,1,4,0)
 ;;=4^V25.09
 ;;^UTILITY(U,$J,358.3,14959,1,5,0)
 ;;=5^Contraceptive Counseling
 ;;^UTILITY(U,$J,358.3,14959,2)
 ;;=^87608
 ;;^UTILITY(U,$J,358.3,14960,0)
 ;;=V25.9^^95^852^4
 ;;^UTILITY(U,$J,358.3,14960,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14960,1,4,0)
 ;;=4^V25.9
 ;;^UTILITY(U,$J,358.3,14960,1,5,0)
 ;;=5^Contraceptive Management
 ;;^UTILITY(U,$J,358.3,14960,2)
 ;;=^276356
 ;;^UTILITY(U,$J,358.3,14961,0)
 ;;=V65.40^^95^852^5
 ;;^UTILITY(U,$J,358.3,14961,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14961,1,4,0)
 ;;=4^V65.40
 ;;^UTILITY(U,$J,358.3,14961,1,5,0)
 ;;=5^Counseling NOS
 ;;^UTILITY(U,$J,358.3,14961,2)
 ;;=^87449
 ;;^UTILITY(U,$J,358.3,14962,0)
 ;;=V58.83^^95^852^6
 ;;^UTILITY(U,$J,358.3,14962,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14962,1,4,0)
 ;;=4^V58.83
 ;;^UTILITY(U,$J,358.3,14962,1,5,0)
 ;;=5^Encounter for Therapeutic Drug Monitor
 ;;^UTILITY(U,$J,358.3,14962,2)
 ;;=^322076
 ;;^UTILITY(U,$J,358.3,14963,0)
 ;;=V18.51^^95^852^18
 ;;^UTILITY(U,$J,358.3,14963,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14963,1,4,0)
 ;;=4^V18.51
 ;;^UTILITY(U,$J,358.3,14963,1,5,0)
 ;;=5^Family h/o Colonic Polyps
 ;;^UTILITY(U,$J,358.3,14963,2)
 ;;=^334209
 ;;^UTILITY(U,$J,358.3,14964,0)
 ;;=V18.59^^95^852^22
 ;;^UTILITY(U,$J,358.3,14964,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14964,1,4,0)
 ;;=4^V18.59
 ;;^UTILITY(U,$J,358.3,14964,1,5,0)
 ;;=5^Family h/o GI Problems
 ;;^UTILITY(U,$J,358.3,14964,2)
 ;;=^334210
 ;;^UTILITY(U,$J,358.3,14965,0)
 ;;=V68.09^^95^852^31
 ;;^UTILITY(U,$J,358.3,14965,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14965,1,4,0)
 ;;=4^V68.09
 ;;^UTILITY(U,$J,358.3,14965,1,5,0)
 ;;=5^Form Completion
 ;;^UTILITY(U,$J,358.3,14965,2)
 ;;=^335321
 ;;^UTILITY(U,$J,358.3,14966,0)
 ;;=V10.51^^95^852^39
 ;;^UTILITY(U,$J,358.3,14966,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14966,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,14966,1,5,0)
 ;;=5^Personal h/o Bladder Cancer
 ;;^UTILITY(U,$J,358.3,14966,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,14967,0)
 ;;=V10.3^^95^852^40
 ;;^UTILITY(U,$J,358.3,14967,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14967,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,14967,1,5,0)
 ;;=5^Personal h/o Breast Cancer
 ;;^UTILITY(U,$J,358.3,14967,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,14968,0)
 ;;=V10.41^^95^852^41
 ;;^UTILITY(U,$J,358.3,14968,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14968,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,14968,1,5,0)
 ;;=5^Personal h/o Cervical Cancer
 ;;^UTILITY(U,$J,358.3,14968,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,14969,0)
 ;;=V10.05^^95^852^42
 ;;^UTILITY(U,$J,358.3,14969,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14969,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,14969,1,5,0)
 ;;=5^Personal h/o Colon Cancer
 ;;^UTILITY(U,$J,358.3,14969,2)
 ;;=^295207
 ;;^UTILITY(U,$J,358.3,14970,0)
 ;;=V10.03^^95^852^47
 ;;^UTILITY(U,$J,358.3,14970,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14970,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,14970,1,5,0)
 ;;=5^Personal h/o Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,14970,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,14971,0)
 ;;=V10.21^^95^852^55
 ;;^UTILITY(U,$J,358.3,14971,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14971,1,4,0)
 ;;=4^V10.21
 ;;^UTILITY(U,$J,358.3,14971,1,5,0)
 ;;=5^Personal h/o Laryngeal Cancer
 ;;^UTILITY(U,$J,358.3,14971,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,14972,0)
 ;;=V10.60^^95^852^56
 ;;^UTILITY(U,$J,358.3,14972,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14972,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,14972,1,5,0)
 ;;=5^Personal h/o Leukemia
 ;;^UTILITY(U,$J,358.3,14972,2)
 ;;=^295231
 ;;^UTILITY(U,$J,358.3,14973,0)
 ;;=V10.11^^95^852^57
 ;;^UTILITY(U,$J,358.3,14973,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14973,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,14973,1,5,0)
 ;;=5^Personal h/o Lung Cancer
 ;;^UTILITY(U,$J,358.3,14973,2)
 ;;=^295211
 ;;^UTILITY(U,$J,358.3,14974,0)
 ;;=V10.79^^95^852^59
 ;;^UTILITY(U,$J,358.3,14974,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14974,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,14974,1,5,0)
 ;;=5^Personal h/o Lymphoma
 ;;^UTILITY(U,$J,358.3,14974,2)
 ;;=^295238
 ;;^UTILITY(U,$J,358.3,14975,0)
 ;;=V10.02^^95^852^65
 ;;^UTILITY(U,$J,358.3,14975,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14975,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,14975,1,5,0)
 ;;=5^Personal h/o Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,14975,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,14976,0)
 ;;=V10.06^^95^852^71
 ;;^UTILITY(U,$J,358.3,14976,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14976,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,14976,1,5,0)
 ;;=5^Personal h/o Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,14976,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,14977,0)
 ;;=V10.52^^95^852^72
 ;;^UTILITY(U,$J,358.3,14977,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14977,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,14977,1,5,0)
 ;;=5^Personal h/o Renal Cancer
 ;;^UTILITY(U,$J,358.3,14977,2)
 ;;=^295229
 ;;^UTILITY(U,$J,358.3,14978,0)
 ;;=V10.04^^95^852^75
 ;;^UTILITY(U,$J,358.3,14978,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14978,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,14978,1,5,0)
 ;;=5^Personal h/o Stomach Cancer
 ;;^UTILITY(U,$J,358.3,14978,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,14979,0)
 ;;=V10.47^^95^852^78
 ;;^UTILITY(U,$J,358.3,14979,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14979,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,14979,1,5,0)
 ;;=5^Personal h/o Testicular Cancer
 ;;^UTILITY(U,$J,358.3,14979,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,14980,0)
 ;;=V08.^^95^852^32
 ;;^UTILITY(U,$J,358.3,14980,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14980,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,14980,1,5,0)
 ;;=5^HIV + Status (Asymptomatic)
 ;;^UTILITY(U,$J,358.3,14980,2)
 ;;=^303392
 ;;^UTILITY(U,$J,358.3,14981,0)
 ;;=V07.4^^95^852^33
 ;;^UTILITY(U,$J,358.3,14981,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14981,1,4,0)
 ;;=4^V07.4
 ;;^UTILITY(U,$J,358.3,14981,1,5,0)
 ;;=5^Hormone Replacement Therapy
 ;;^UTILITY(U,$J,358.3,14981,2)
 ;;=^331975
 ;;^UTILITY(U,$J,358.3,14982,0)
 ;;=V13.59^^95^852^63
 ;;^UTILITY(U,$J,358.3,14982,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14982,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,14982,1,5,0)
 ;;=5^Personal h/o Musculoskletl Dis
 ;;^UTILITY(U,$J,358.3,14982,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,14983,0)
 ;;=V12.51^^95^852^45
 ;;^UTILITY(U,$J,358.3,14983,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14983,1,4,0)
 ;;=4^V12.51
